Medical Foods and Formulas Access Act of 2025
- Bill Number
- S. 3304
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-12-02: Read twice and referred to the Committee on Finance.
- Last Updated
- 2026-06-09T20:30:30Z
AI-Generated Summary
Purpose
The Medical Foods and Formulas Access Act of 2025 aims to mandate coverage for medically necessary foods, vitamins, and individual amino acids—specialized nutritional products prescribed for managing digestive and inherited metabolic disorders—under key federal health programs. It seeks to prevent severe health risks like malnutrition, developmental delays, and death by ensuring access to these treatments, while protecting existing state-level coverage and encouraging similar benefits in private insurance.
Key Provisions
- Definition of Medically Necessary Food: Establishes a clear definition under the Social Security Act, covering specially formulated products (e.g., low-protein foods, amino acid preparations, nutritional formulas, vitamins, or individual amino acids) prescribed by qualified healthcare providers for dietary management of specific conditions. These must be used under medical supervision and exclude general diet aids, gluten-free foods for celiac disease, or diabetes management products. Covered conditions include inherited metabolic disorders (e.g., urea cycle disorders, fatty acid oxidation issues), malabsorption conditions (e.g., short bowel syndrome), food protein allergies, inflammatory bowel diseases (e.g., Crohn's disease), and others determined by the Secretary of Health and Human Services.
- Coverage Requirements:
- Medicare (Part B): Adds coverage for medically necessary food and related equipment/supplies (e.g., feeding tubes if needed), paid at 80% of the lesser of the provider's charge or a fee schedule set by the Secretary. Excludes items already covered under standard Part B.
- Medicaid: Makes coverage mandatory as a core benefit, including in benchmark or equivalent plans; states cannot limit it in ways that increase costs unnecessarily.
- Children's Health Insurance Program (CHIP): Requires coverage for eligible children as a standard benefit.
- Federal Employees Health Benefits Program (FEHBP): Mandates inclusion in contracts for federal employee plans.
- Implementation Timelines:
- Medicare: Effective 3 years after enactment.
- Medicaid and CHIP: Effective 2 years and 1 year after enactment, respectively, with delays if state laws need updating (up to the end of the next legislative session).
- FEHBP: Effective for contract years starting 1 year after enactment.
- Additional Guidance:
- Expresses a "sense of Congress" urging private health insurers to provide similar coverage.
- Prohibits preemption of state laws offering broader coverage.
- Allows coverage for combinations of these products with other necessary supplies.
Significant Changes to Existing Law
- Amends the Social Security Act to explicitly include medically necessary foods as covered items under Medicare (Section 1861(s)(2)), Medicaid (Section 1905(a)), and CHIP (Section 2103(c)), which previously treated these variably as optional or excluded from standard benefits.
- Introduces a new subsection (1861(nnn)) defining "medically necessary food" for the first time in federal statute, standardizing what qualifies and excluding non-specialized items.
- Updates payment rules in Medicare (Section 1833(a)) to create a dedicated fee schedule, shifting from inconsistent or absent reimbursement.
- Ensures Medicaid benchmark plans cannot opt out, closing gaps in state variability.
- Adds requirements to FEHBP contracts (5 U.S.C. § 8902), extending coverage to federal workers and dependents.
Potential Impacts
- On Citizens: Improves access to essential, life-sustaining nutrition for thousands affected by rare disorders (e.g., ~2,000 newborns annually diagnosed via mandatory screening), potentially reducing hospitalizations, surgeries, intellectual disabilities, and deaths. Addresses issues like the 2022 formula shortage by prioritizing oral or tube-fed options over more invasive treatments.
- On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) and Office of Personnel Management (OPM) must develop fee schedules, update regulations, and monitor compliance, increasing administrative workload and program costs (e.g., higher reimbursements). States may face initial budgeting pressures for Medicaid/CHIP expansions but gain flexibility for legislation.
- On International Relations: No direct impacts; the bill focuses on domestic U.S. health policy.
Main Stakeholders Affected
- Patients and Families: Primarily children and adults with inherited metabolic disorders, digestive issues (e.g., short bowel syndrome, eosinophilic disorders), or allergies, who rely on these products to avoid malnutrition.
- Healthcare Providers: Physicians, physician assistants, nurse practitioners, and dietitians who prescribe and monitor these treatments, gaining clearer guidelines for patient care.
- Federal and State Governments: CMS for implementation; states for Medicaid/CHIP adjustments; federal employees and retirees via FEHBP.
- Insurers and Manufacturers: Private plans encouraged to cover; producers of medical foods (e.g., formulas, amino acids) may see increased demand and reimbursement stability.
- Broader Healthcare System: Hospitals and emergency services could see fewer visits due to better preventive nutrition.
Notable Legal, Constitutional, or Political Implications
- Legal: Standardizes coverage across federal programs, reducing litigation over denials by clarifying "medically necessary" criteria and prohibiting arbitrary restrictions (e.g., mandating feeding tubes). Non-preemption clause preserves state autonomy, avoiding federal overreach challenges.
- Constitutional: No apparent conflicts; aligns with Congress's authority under the Spending Clause to condition federal health funding on coverage requirements, promoting equal access without infringing on individual rights.
- Political: Bipartisan sponsorship (e.g., Sens. Wicker, Klobuchar, Grassley, Whitehouse) signals broad support for addressing pediatric and rare disease needs, highlighted by events like the 2022 shortage. May influence future expansions of nutritional benefits in health reform debates, emphasizing preventive care over costly interventions.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (6)
Sen. Klobuchar, Amy [D-MN], Sen. Grassley, Chuck [R-IA], Sen. Whitehouse, Sheldon [D-RI], Sen. Ossoff, Jon [D-GA], Sen. Coons, Christopher A. [D-DE], Sen. Warnock, Raphael G. [D-GA]
Recent Actions
- 2025-12-02: Read twice and referred to the Committee on Finance.
- 2025-12-02: Introduced in Senate
Bill Versions
- Medical Foods and Formulas Access Act of 2025 — issued 2025-12-02 — PDF (17 pages)